M. Lamson

发表

Effects of concurrent intravenous morphine sulfate and naltrexone hydrochloride on end-tidal carbon dioxide

L. Webster, J. Cleveland, K. Sommerville, 2012, Harm Reduction Journal.

Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers

T. Macgregor, A. Hawi, M. Lamson, 1999, Biopharmaceutics & drug disposition.

Nevirapine Induces Both CYP3A4 and CYP2B6 Metabolic Pathways

T. Macgregor, J. Keirns, M. Lamson, 1999 .

Effects of hexagonal phase induction by dolichol on phospholipid membrane permeability and morphology

J. Carson, F. Morgan, L. Herbette, 1994 .

Prediction of acetaminophen level from clinical history of overdose using a pharmacokinetic model.

F. Lovejoy, M. Lamson, D. A. Edwards, 1986, Annals of emergency medicine.

Pharmacokinetic Interaction Between Nevirapine and Ethinyl Estradiol/Norethindrone When Administered Concurrently to HIV‐Infected Women

D. Mildvan, M. Lamson, A. Marshak, 2002, Journal of acquired immune deficiency syndromes.

Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1.

R. Murphy, M. Myers, J. Sommadossi, 1999, The Journal of infectious diseases.

Pharmacokinetics of Diazepam Administered Intramuscularly by Autoinjector versus Rectal Gel in Healthy Subjects

J. Pellock, M. Lamson, Diane Sitki-Green, 2011, Clinical drug investigation.

Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone

R. Gomeni, P. Loupe, O. Spiegelstein, 2022, Clinical pharmacology in drug development.

Disposition and biotransformation of the antiretroviral drug nevirapine in humans.

T. Macgregor, J. Keirns, M. Lamson, 1999, Drug metabolism and disposition: the biological fate of chemicals.

Pharmacokinetics of nevirapine and lamivudine in patients with HIV-1 infection

T. Macgregor, G. Leitz, C. Yong, 2000, AAPS PharmSci.

Pharmacokinetics, safety, and activity of nevirapine in human immunodeficiency virus type 1-infected children.

J. Sullivan, K. Luzuriaga, Y. Bryson, 1996, The Journal of infectious diseases.

Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection.

P. Krogstad, J. Sullivan, K. Luzuriaga, 1997, The New England journal of medicine.

Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas.

C. Brennan, L. Deangelis, P. Gutin, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single‐ and multiple‐dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended‐release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended‐release oxycodone with sequestered naltrexone 80 mg once d

Joanne Salageanu, Kyle T. Matschke, B. Malhotra, 2015 .

Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO‐02, an extended release formulation of oxycodone with sequestered naltrexone

Joanne Salageanu, Kyle T. Matschke, B. Malhotra, 2015, Clinical pharmacology in drug development.

Single- and Multiple-Dose Study to Evaluate Pharmacokinetics, Safety and Tolerability in Healthy Volunteers: A Comparison of Extended-Release Oxycodone With Sequestered Naltrexone 40mg Twice Daily to OxyContin 40mg Twice Daily and Extended-Release Oxycodone With Sequestered Naltrexone 80mg Once Dail

Joanne Salageanu, Kyle T. Matschke, B. Malhotra, 2015 .

A pharmacokinetic study of lipegfilgrastim in children with Ewing family of tumors or rhabdomyosarcoma

A. Lammerich, M. Garami, M. Belogurova, 2016, Cancer Chemotherapy and Pharmacology.

Pharmacokinetic interaction between nevirapine and ethinyl estradiol/norethindrone when administered concurrently to HIV-infected women.

D. Mildvan, M. Lamson, A. Marshak, 2002 .

P.0463 Phase 1 open-label study assessing the pharmacokinetics and safety of TV-46000, a novel long-acting subcutaneous injectable formulation of risperidone

O. Spiegelstein, A. M. Wagner, M. Lamson, 2021, European Neuropsychopharmacology.

Pharmacokinetics and safety of binodenoson after intravenous dose escalation in healthy volunteers

James R. Johnson, William B. Smith, M. Lamson, 2005, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Pharmacokinetics of lovastatin extended‐release dosage form (Lovastatin XL) in healthy volunteers

L. Friedhoff, M. Lamson, P. Lukacsko, 2002, Biopharmaceutics & drug disposition.